secwatch.observer — SEC 8-K summary
======================================

Issuer:     HALOZYME THERAPEUTICS, INC. (HALO)
CIK:        0001159036
Form:       8-K
Filed at:   2022-03-15T23:59:59+00:00
Accession:  0001159036-22-000019
Event type: leadership
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Moni Miyashita elected to Halozyme Board of Directors
-----------------------------------------------------

- Elected March 11, 2022, term ends at 2023 annual meeting.
- No initial committee assignment on the Board.
- Receives standard non-employee director compensation (cash retainers and restricted stock).
- No arrangements, understandings, or related person transactions with the Company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1159036/000115903622000019/0001159036-22-000019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1159036/000115903622000019/halo-20220315.htm
  HTML page:      https://secwatch.observer/filing/0001159036-22-000019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer